Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Days Inventory : 137.80 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Biocytogen Pharmaceuticals (Beijing) Co Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Biocytogen Pharmaceuticals (Beijing) Co's Average Total Inventories for the six months ended in Dec. 2023 was HK$98.6 Mil. Biocytogen Pharmaceuticals (Beijing) Co's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$130.6 Mil. Hence, Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory for the six months ended in Dec. 2023 was 137.80.

The historical rank and industry rank for Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory or its related term are showing as below:

HKSE:02315' s Days Inventory Range Over the Past 10 Years
Min: 160.06 Med: 241.6 Max: 260.73
Current: 160.06

During the past 4 years, Biocytogen Pharmaceuticals (Beijing) Co's highest Days Inventory was 260.73. The lowest was 160.06. And the median was 241.60.

HKSE:02315's Days Inventory is ranked better than
57.58% of 653 companies
in the Biotechnology industry
Industry Median: 192.72 vs HKSE:02315: 160.06

Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory declined from Dec. 2022 (234.97) to Dec. 2023 (137.80).

Inventory Turnover measures how fast the company turns over its inventory within a year. Biocytogen Pharmaceuticals (Beijing) Co's Inventory Turnover for the six months ended in Dec. 2023 was 1.32.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Biocytogen Pharmaceuticals (Beijing) Co's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.23.

Biocytogen Pharmaceuticals (Beijing) Co Days Inventory Historical Data

The historical data trend for Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocytogen Pharmaceuticals (Beijing) Co Days Inventory Chart

Biocytogen Pharmaceuticals (Beijing) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Days Inventory

260.73

243.85

239.35

161.17

Biocytogen Pharmaceuticals (Beijing) Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial			233.32	282.68	234.97	187.83	137.80

Competitive Comparison of Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory

For the Biotechnology subindustry, Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory falls into.

Biocytogen Pharmaceuticals (Beijing) Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (106.202	+	97.491)	/	2 )	/	230.654	*	365
=	101.8465					/	230.654	*	365
=	161.17

Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (99.741	+	97.491)	/	2 )	/	130.604	*	365 / 2
=	98.616					/	130.604	*	365 / 2
=	137.80

Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Biocytogen Pharmaceuticals (Beijing) Co's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	130.604	/	98.616
	=	1.32

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Biocytogen Pharmaceuticals (Beijing) Co's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	98.616	/	426.657
	=	0.23

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Biocytogen Pharmaceuticals (Beijing) Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Biocytogen Pharmaceuticals (Beijing) Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

I54:Germany

Address

12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District, Beijing, CHN

Website

https://www.biocytogen.com.cn

Biocytogen Pharmaceuticals (Beijing) Co Ltd is a biopharmaceutical and pre-clinical research services company. It has two Core Products, YH003 and YH001. YH003 is a recombinant humanized agonistic anti-Cluster of Differentiation 40 (CD40) Immunoglobulin G2 (IgG2) monoclonal antibody and YH001 is a recombinant humanized anti-CTLA-4, a protein receptor expressed constitutively on T cells that functions as an immune checkpoint and downregulates immune responses, Immunoglobulin G1 (IgG1) monoclonal antibody. YH003 is being developed for pancreatic ductal adenocarcinoma, melanoma and other advanced solid tumors. YH001 is being developed for hepatocellular carcinoma (HCC), non-small-cell lung carcinoma (NSCLC) and other solid tumors.

Executives

Bvcf Realization Fund, L.p.	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Prowell Ventures Pte Ltd	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Gic Private Limited	2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Yang Zhi	2201 Interest of corporation controlled by you
Innoveda Medtech, Ltd.	2201 Interest of corporation controlled by you
Ni Jian
Bvcf Realization Fund Gp, Ltd.	2201 Interest of corporation controlled by you
Bioveda China Fund Ii Rmb, Limited	2101 Beneficial owner
Cmbi Private Equity Series Spc	2201 Interest of corporation controlled by you
Cmb International Private Investment Limited	2201 Interest of corporation controlled by you
Cmb International Investment Management Limited	2201 Interest of corporation controlled by you

Biocytogen Pharmaceuticals (Beijing) Co (HKSE:02315) Headlines

No Headlines